Dna X (SONM) Return on Sales (2018 - 2025)

Dna X has reported Return on Sales for 8 years, with the latest figure at 0.0% in Q3 2025.

• For the quarter ending Q3 2025, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Sep 2025 stood at 0.0% (changed 0.0% YoY), and the FY2024 full-year result was 0.01%, down 1.0% from the prior year.
• Return on Sales for Q3 2025 stood at 0.0%, up from 0.01% in the prior quarter.
• The five-year high for Return on Sales was 0.01% in Q4 2024, with the low at 0.01% in Q1 2021.
• Historically, Return on Sales has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
• Annual changes were most pronounced in 2021 — Return on Sales fell 2 bps — and 2022, when it gained 1 bps.
• Dna X's Return on Sales stood at 0.01% in 2021, then surged by 93 bps to 0.0% in 2022, then plunged by 33 bps to 0.0% in 2023, then surged by 1027 bps to 0.01% in 2024, then plunged by 149 bps to 0.0% in 2025.
• The last three Return on Sales figures came in at 0.0% (Q3 2025), 0.01% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.